Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Prehabilitation and early screening, together with BIS, can ease restoration, cut back uncomfortable side effects and assist handle lymphedema after breast most cancers...
New medical trials are advancing in hard-to-treat cancers, providing focused and fewer poisonous choices for sufferers with restricted therapy paths.New medical trials are...
Jane Biehl is a 12-year survivor of a really uncommon type of blood most cancers, generally known as myelodysplastic syndrome (MDS). Make amends for...
